🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Colgate-Palmolive shares target upped, but valuation concerns persist - Jefferies

EditorEmilio Ghigini
Published 07/29/2024, 06:36 AM
CL
-

On Monday, Jefferies maintained a Hold rating on Colgate-Palmolive Company (NYSE: NYSE:CL), while increasing the shares target to $101 from $95. The adjustment follows Colgate-Palmolive's recent quarterly performance, which was characterized by strong volume growth and margin expansion, indicating that the company's brand reinvestment strategies are yielding positive results.

The report acknowledged that Colgate-Palmolive delivered an exceptional quarter, which was necessary to justify its 27x next twelve months (NTM) price-to-earnings (P/E) multiple. The company's efforts in brand reinvestment have been effective, leading to a sequential rise in volumes and robust margin expansion.

Despite the positive outcomes, the analyst expressed caution regarding the sustainability of such performance. The second half of the year presents more challenging comparisons, and there is a noted weakening of the consumer base in North America and Europe. These factors contribute to the perspective that while the company's long-term fundamentals are seen positively, the current valuation may already reflect much of the good news.

In other recent news, Colgate-Palmolive Company has been making significant strides in its financial performance. The company reported robust growth in the second quarter of 2024, with a return to mid single-digit volume growth and expanding gross margins. This success was attributed to innovation, strategic marketing, and the use of data analytics and AI tools. The Hill's business segment notably contributed to the company's market share gains.

Evercore ISI recently adjusted its financial outlook for Colgate-Palmolive, raising the price target from $106 to $112 while maintaining an Outperform rating. The firm highlighted Colgate's strong growth prospects and high return on invested capital within the household and personal care industry. Evercore ISI also increased its earnings per share estimates for the company for 2024 and 2025.

Despite potential industry deceleration in Europe, Colgate-Palmolive maintained solid volume growth and plans to continue this trajectory with a consistent pricing and promotional strategy. The company also reported favorable volume growth in various markets, particularly in Brazil and Mexico. These are among the recent developments for the multinational consumer products company.

InvestingPro Insights

As Colgate-Palmolive (NYSE: CL) continues to impress the market with its strong quarterly performance, a deeper dive into the company's financial health and stock behavior using InvestingPro data can provide investors with a more nuanced perspective. Notably, Colgate-Palmolive's market capitalization stands at a robust $81.21B, reflecting the company's significant presence in the industry. The current P/E ratio is 28.96, which is slightly above the adjusted P/E ratio for the last twelve months as of Q2 2024, indicating a stable valuation over time.

InvestingPro Tips highlight that Colgate-Palmolive has raised its dividend for 34 consecutive years and maintains a positive outlook with 6 analysts having revised their earnings upwards for the upcoming period. This consistent dividend growth, coupled with a strong gross profit margin of 59.7%, underscores the company's ability to generate substantial profitability from its sales. Additionally, the company's stock is characterized by low price volatility, which might appeal to investors seeking a stable investment.

For those considering an investment in Colgate-Palmolive, it is worth noting that there are more InvestingPro Tips available to help guide your decision. By using the coupon code PRONEWS24, investors can get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription, providing access to a total of 13 additional InvestingPro Tips that can further inform investment strategies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.